ridm@nrct.go.th   ระบบคลังข้อมูลงานวิจัยไทย   รายการโปรดที่คุณเลือกไว้

Prevalence of Cardiovascular Complications and Anti-platelet Therapy Used among Thai Type 2 Diabetes Patients in 2012

หน่วยงาน จุฬาลงกรณ์มหาวิทยาลัย

รายละเอียด

ชื่อเรื่อง : Prevalence of Cardiovascular Complications and Anti-platelet Therapy Used among Thai Type 2 Diabetes Patients in 2012
นักวิจัย : Soe Sandi Tint
คำค้น : -
หน่วยงาน : จุฬาลงกรณ์มหาวิทยาลัย
ผู้ร่วมงาน : Pichet Sampatanukul , Chulalongkorn University. Faculty of Medicine
ปีพิมพ์ : 2557
อ้างอิง : http://cuir.car.chula.ac.th/handle/123456789/46248
ที่มา : -
ความเชี่ยวชาญ : -
ความสัมพันธ์ : -
ขอบเขตของเนื้อหา : -
บทคัดย่อ/คำอธิบาย :

Background: Diabetes Mellitus type 2 (T2DM) is one of the global pandemic that can cause several chronic complications. The macro vascular complication is able to be prevented somehow by anti-platelet therapy. The primary and secondary prevention programs were analyzed at different levels of cares among Thai T2DM patients in 2012. Objective: To describe the prevalence of cardiovascular complications and the percentage of anti-platelet prescriptions without and with cardiovascular complications events at different levels of cares among Thai T2DM patients in 2012. Materials and method: This study was part of the Thailand DM/HT study. The data was retrospectively collected from the medical records from a stratified sampling of public hospitals under Ministry of Public Health and hospitals and clinics in Bangkok that under the national health security office program, altogether 602 institutes. The authors used this secondary source data set to analyze. Results: Of the 29,374 T2DM patients, 5.8% (95% CI: 5.6 to 6.2) had overall cardiovascular complications and 7%, 8.2% and 4.6 % were from regional center hospital, provincial general hospital and community hospital respectively. Overall 84.8% (95% CI: 82.9 to 86.6) of T2DM patients with cardiovascular complications were prescribed anti-platelet medications and 57.1% (95% CI: 56.5 to 57.7) of patients with no cardiovascular complications were prescribed anti-platelet therapy. Most patients with cardiovascular complications went to community hospital for anti-platelet drugs. Prescriptions in non-cardiovascular complications group were more likely in male and older patients, history with quit smoking and hypertension patients. Conclusion: The overall prevalence of cardiovascular complications in Thai T2DM patients in 2012 was in the range of expectation. The use of anti-platelet therapy as secondary prevention was lower than the target figure of 90%.

Thesis (M.Sc.)--Chulalongkorn University, 2014

บรรณานุกรม :
Soe Sandi Tint . (2557). Prevalence of Cardiovascular Complications and Anti-platelet Therapy Used among Thai Type 2 Diabetes Patients in 2012.
    กรุงเทพมหานคร : จุฬาลงกรณ์มหาวิทยาลัย.
Soe Sandi Tint . 2557. "Prevalence of Cardiovascular Complications and Anti-platelet Therapy Used among Thai Type 2 Diabetes Patients in 2012".
    กรุงเทพมหานคร : จุฬาลงกรณ์มหาวิทยาลัย.
Soe Sandi Tint . "Prevalence of Cardiovascular Complications and Anti-platelet Therapy Used among Thai Type 2 Diabetes Patients in 2012."
    กรุงเทพมหานคร : จุฬาลงกรณ์มหาวิทยาลัย, 2557. Print.
Soe Sandi Tint . Prevalence of Cardiovascular Complications and Anti-platelet Therapy Used among Thai Type 2 Diabetes Patients in 2012. กรุงเทพมหานคร : จุฬาลงกรณ์มหาวิทยาลัย; 2557.